Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-22

Clinical Trial Update: Efficacy of a Single Dose Dexamethasone in Reducing the Postembolization Syndrome in Men Undergoing Prostatic Artery Embolization for Benign Prostatic Hyperplasia [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether a single dose of dexamethasone reduces postembolization syndrome after prostatic artery embolization for benign prostatic hyper…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Prostatic Hyperplasia | Phase 4 | Status: UNKNOWN